ClinicalTrials.gg
Not yet recruitingNCT07827508SSPT-AUpdated Sep 18, 2026

Assessment of Childbirth-Related Post-Traumatic Stress Disorder

An interventional study of City Birth Trauma Scale and Questionnaire on the assessment of healthcare utilization in Childbirth-related Post-traumatic Stress Disorder, sponsored by Groupe Hospitalier de la Region de Mulhouse et Sud Alsace. Not yet recruiting at 1 site in France. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-18.

Sponsored by Groupe Hospitalier de la Region de Mulhouse et Sud Alsace · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
1,000
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Study summary

The main objective of this study is to estimate the prevalence of childbirth-related post-traumatic stress disorder (PTSD) among mothers treated at the maternity ward of Emile Muller Hospital (Mulhouse, Haut-Rhin, France).

Read the detailed description

Secondary objectives

  1. To identify risk factors associated with the development of PTSD, in order to determine which situations-particularly obstetric ones-could lead women to experience trauma, and understand the underlying psychological mechanisms.

    Risk factors identified in the literature or deemed relevant by the study's clinicians and psychologists will be gathered from medical records.

  2. To assess healthcare utilization in the context of the onset of childbirth-related PTSD from the women's perspective, using a questionnaire consisting of a series of questions about the different healthcare professionals consulted during the month following childbirth.

Conduct of research About one month after giving birth, women who have provided their consent will receive an email containing a personal link to the eCRF page where they will find the French version of the "City Birth Trauma Scale" (CBTS) questionnaire, as well as the questionnaire designed to assess their use of healthcare services.

After completing the CBTS questionnaire, the participant can choose to check a box in the eCRF to indicate whether or not she wishes to be contacted by the research team in the event that her score suggests a diagnosis of PTSD.

If the participant has not completed the questionnaire within 10 days of receiving the link, a follow-up email will be sent to her. If, after receiving this follow-up email, the participant has not completed the questionnaire or contacted the research team, she will be considered lost to follow-up.

02

Conditions studied

  • Childbirth-related Post-traumatic Stress Disorder

Keywords

  • Parturition
  • Post Traumatic Stress Disorder
  • Screening
  • City Birth Trauma Scale
03

In context

Stress Disorders, Post-Traumatic

2,682 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 601 are open to participants now.

This study's planned enrollment of 1,000 is above the median of 69 across 2,196 interventional studies indexed under Stress Disorders, Post-Traumatic.

Browse Stress Disorders, Post-Traumatic studies →

Lead sponsor

Groupe Hospitalier de la Region de Mulhouse et Sud Alsace is the lead sponsor of 27 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Women aged 18 or older
  • Having given birth in the maternity ward at Emile Muller Hospital (Mulhouse, Haut-Rhin, France)
  • Fluent in French
  • Having provided written consent to participate in the study
  • Being covered by a social security program

Exclusion criteria

Exclusion Criteria:

  • Women who gave birth anonymously
  • Women who gave birth to a stillborn child or a fetus that died in utero
  • Women under legal protection (guardianship, conservatorship, judicial protection).
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
1,000 participants (estimated)

Study arms

  • Other
    Women who have given birth within the past month

    Diagnostic Test: City Birth Trauma Scale and Questionnaire on the assessment of healthcare utilization

Interventions

  • Diagnostic testCity Birth Trauma Scale and Questionnaire on the assessment of healthcare utilization

    About one month after giving birth, patients who have given their consent will receive an email containing a personal link to the eCRF page with the French version of the City Birth Trauma Scale (CBTS) questionnaire, as well as a questionnaire to assess their use of healthcare services. After completing the CBTS questionnaire, the participant can choose to check a box in the eCRF to indicate whether or not she wishes to be contacted by the research team in the event that her score suggests a diagnosis of PTSD.

06

What researchers measure

Primary outcomes

  1. City Birth Trauma Scale

    The diagnosis of PTSD based on responses to the questionnaire will be made in accordance with the questionnaire's scoring method, which assesses 8 criteria based on the DSM-5 (criteria labeled A through H).

    Time frame: About 1 month after childbirth

Secondary outcomes

  1. Questionnaire on the assessment of healthcare utilization

    A ten-item questionnaire to assess the use of healthcare services in the context of postpartum post-traumatic stress disorder from the women's perspective, enquiring about the healthcare professionals these women consulted during the month following childbirth.

    Time frame: About 1 month after childbirth

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07827508
Lead sponsor
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
Responsible party
Sponsor
First posted
Sep 18, 2026
Start date
Oct 1, 2026 (estimated)
Primary completion
Jun 30, 2027 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Sep 18, 2026

Study contacts

Edgar Yohny Montoya Ramirez, MD
Contact
montoyaramireze@ghrmsa.fr
+33 3 89 64 64 64

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion